Allstate Corp Novo Cure LTD Transaction History

Allstate Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $5,438 - $7,256	85 Added 2.2%	3,956 $290,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $1,223 - $1,612	-18 Reduced 0.46%	3,871 $294,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $44,770 - $71,110	-791 Reduced 16.9%	3,889 $270,000
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $281,502 - $395,553	4,680 New	4,680 $388,000
Q4 2021 Feb 15, 2022	SELL	$75.08 - $121.99 $223,663 - $363,408	-2,979 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $60,292 - $100,971	519 Added 21.1%	2,979 $346,000
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $320,784 - $554,926	2,460 New	2,460 $546,000
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $148,311 - $227,253	-1,195 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $134,031 - $208,097	1,195 New	1,195 $207,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.